Febuxostat Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency (DLA) plans to issue a solicitation for a national requirements contract to supply Febuxostat Tablets in 40 mg and 80 mg dosages, packaged in 30-count bottles. This procurement will be unrestricted and fully competitive, structured as a firm-fixed price, requirements-type contract with a one-year base period and four one-year options. The contract aims to establish a national supply source under FAR 52.216-21, enabling purchases by various federal agencies including the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service through DLA and VA prime vendor programs. Estimated annual usage details will be available in the solicitation's Schedule of Supplies, and the acquisition will follow FAR part 12 guidelines for commercial items, welcoming proposals from all interested sources. The solicitation, designated SPE2D2-26-R-0012, is expected to be posted around June 2026 on the DLA Bid Board System (DIBBS) and SAM.gov, with the DLA retaining the option to adjust the timeline. The point of contact for inquiries is Christopher Newman, with a secondary contact of Jason C. Wray, both reachable via email and phone. Potential offerors are encouraged to set up automated notifications on the procurement websites to stay informed of any updates or changes related to this solicitation. The contract supports the acquisition of Febuxostat Tablets under NAICS code 325412 and will be managed by the DLA Troop Support office based in Philadelphia, PA.
General Info
Agency
NAICS
Place of Performance
PASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Febuxostat Tablets. Procurement details follow.
Febuxostat Tablets: 40 MG and 80 MG Tablets in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Christopher Newman at (445) 737-7371 or Christopher.Newman@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is June of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.